\
&
Contact us
Starts in 1 week from now
LocationValletta (MT)
The next edition of EFECS – the European Forum for Electronic Components and Systems is set for December 3–4, 2025 in Malta (at the same location of the inaugural ECSEL Symposium in 2017). The event will focus on boosting innovation and European competitiveness in the ECS sector. There is a pre-programme on Euroean Chips Design Platform on December 2nd.
This year's theme, "Accelerate Innovation: Building European Competitiveness," emphasizes value chain security, sustainability, and the exploration of emerging market opportunities. Key features include insightful keynotes and discussions on cutting-edge topics like quantum tech, cybersecurity, and AI.
What to expect?
For more info and registration, visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
Research Infrastructures Culture and society Climate, Energy, Mobility
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.